Learn More
Invitrogen™ SETDB2 Polyclonal Antibody

Description
Additional Information: This antibody is expected to recognize both reported isoforms (NP_114121.2; NP_001153780.1). This antibody is tested in Peptide ELISA: antibody detection limit dilution 1:32,000.
Specifications
Specifications
| Antigen | SETDB2 |
| Applications | Western Blot |
| Classification | Polyclonal |
| Concentration | 0.5 mg/mL |
| Conjugate | Unconjugated |
| Formulation | TBS with 0.5% BSA and 0.02% sodium azide; pH 7.3 |
| Gene | SETDB2 |
| Gene Accession No. | Q96T68 |
| Gene Alias | bifurcated 2; C13orf4; Chronic lymphocytic leukemia deletion region gene 8 protein; Clld8; CLLL8; CLLL8 protein; DKFZp586I0123; DKFZp761J1217; Gm293; Histone-lysine N-methyltransferase SETDB2; KMT1F; Lysine N-methyltransferase 1F; SET domain; SET domain bifurcated 2; SET domain, bifurcated 2; Setdb2; Setdb2-Phf11-1-Phf11-2 fusion |
| Gene Symbols | SETDB2 |
| Show More |
Safety and Handling
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.